35 results on '"Juliusson, Gunnar"'
Search Results
2. Venetoclax with intensive chemotherapy in younger patients with acute myeloid leukaemia
3. P-184: Regional differences in treatment and outcome for myeloma patients in Sweden: a population based Swedish Myeloma Register study
4. AML-063: A Randomized, Double-Blind, Placebo-Controlled Study of Venetoclax with Azacitidine Versus Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia Ineligible for Intensive Therapy-Viale-A
5. Over 10 years relative median survival in MM patients ≤ 65 years with VGPR or better on 1st line treatment. Population-based data on patients diagnosed 2008-2018 from the Swedish Myeloma Registry
6. Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
7. Differentiation targeted compound screen of acute myeloid leukemia
8. Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
9. A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe
10. Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
11. 924 Long-Term Outcomes in Antimitochondrial Antibody Negative Primary Biliary Cirrhosis
12. Mo1141 Biliary Tract Malignancies in Iceland: Epidemiology and Prognosis - A Nationwide Population Based Study
13. Mo1419 Incidence, Clinical Features and Outcome of Patients Diagnosed With Cancer of the Pancreas During 1986-2009: A Population Based Study
14. IGHV3-21 Gene Frequency in a Swedish Cohort of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
15. Older Patients With Acute Myeloid Leukemia Benefit From Intensive Chemotherapy: An Update From the Swedish Acute Leukemia Registry
16. TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
17. Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
18. Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia
19. Mechanisms of anti-cancer action and pharmacology of clofarabine
20. High-Dose Iodine-131-Metaiodobenzylguanidine with Haploidentical Stem Cell Transplantation and Posttransplant Immunotherapy in Children with Relapsed/Refractory Neuroblastoma
21. Purine Analogues: Rationale for Development, Mechanisms of Action, and Pharmacokinetics in Hairy Cell Leukemia
22. The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia
23. Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia
24. A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
25. Long-term endoscopic remission in a case of Crohn's disease after autologous bone marrow transplantation
26. Infections at a hematology ward in a university hospital — Cost and preventive nursing
27. Cladribine (CdA) therapy in chronic lymphocytic leukemia (CLL) - Long-term follow-up of 117 patients
28. Relationship between cladribine (CDA) plasma, intracellular cladribine-5-triphosphate (CDATP) concentration, deoxycytidine kinase (DCK) and chemotherapeutic activity in chronic lymphocytic leukemia (CLL)
29. Bioavailability and bacterial degradation of rectally administered 2-chloro-2′-deoxyadenosine
30. 5 Cytogenetics in CLL and related disorders
31. Complete remission of B-cell chronic lymphocytic leukaemia after oral cladribine
32. No evidence of trisomy 12 or t(11;14) by molecular genetic techniques in chronic lymphocytic leukemia cells with a normal karyotype
33. Chromosome aberrations in B-cell chronic lymphocytic leukemia
34. Del(3)(p13) in B-prolymphocytic leukemia—A new nonrandom chromosomal aberration possibly related to the c-ras oncogene
35. Abnormal/normal metaphase ratio and prognosis in chronic B-lymphocytic leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.